This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Quinagolide

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Quinagolide is a D2 dopamine receptor agonist which may be used to treat hyperprolactinaemia.

Quinagolide is as effective as bromocriptine in reducing prolactin levels and is as well tolerated as once-daily bromocriptine.

Quinagolide is more expensive than the other dopmaine receptor agonists and is probably worth considering only in patients resistant to bromocriptine and cabergoline (1).

Reference:

  1. Drug and Therapeutics Bulletin 1995; 33(9):65-7.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.